Tag Archives: Reports

Hannon Hill Releases Cascade Server 7.4 with In-context Editing and Stale Content material Reports

Posted on by

Atlanta, GA (PRWEB) June 27, 2013

Hannon Hill Corporation, creator of the premier enterprise content material management technique (CMS) for Higher Education, has released Cascade Server 7.4. The newest version of its business-leading CMS software introduces a number of key new features developed to improve the editing encounter and user interface for both finish users and internet developers.

&#13

User Interface (UI) improvements for content contributors include in-context editing, permitting contributors the capacity to edit regions of content from the Layout view of a Web page, drafts for new assets, which auto-saves the progress of new assets, and a new editing UI with always-visible Submit and Cancel buttons. In addition, previewing content material in the course of the creation stage will enable users to see how their web page appears just before officially generating it, a time-saver for every person, particularly organizations utilizing workflows.

&#13

Cascade Server 7.4 also introduces all new reporting on Stale Content in the technique. Content material editors and administrators will now be capable to see the number and percentage of pages and pictures that are out of date or up for review. Colorful dashboard charts give a visual explanation of the general freshness of a web site, based on what is out of date or needs to be updated.

&#13

As Hannon Hills CEO Kat Liendgens notes, Search Engines continue to update their algorithms, creating the freshness of content increasingly crucial. Cascade Server 7.4 empowers users to set review dates on the fly, acquire e mail reminders, and quickly access content assets that are becoming stale.

&#13

Hannon Hills Vice President of Engineering Bradley Wagner stated of the release, Cascade Server 7.four is a giant step forward for Hannon Hill and its customers. The new end-user editing and the content material reports are a game changer. We’re excited to give organizations a much more extensive overview of their content and their customers a simpler editing experience.

&#13

An crucial new feature for internet developers is the new Sophisticated Code Editor for Blocks, Templates, Files, and Formats. This replaces the current editor and can deal with more content material, snippets, and code formatting it also provides far better syntax highlighting. The newest release also introduces new Velocity Locator Tools, which let Velocity Formats to be rendered in regions where no block is assigned, as they can find assets straight in Formats instead of possessing to use Index Blocks to “find” content material.

&#13

For techies like me that really like writing code, the new Advanced Code Editor tends to make coding in Cascade Server considerably much more enjoyable, stated Charlie Holder, Hannon Hills Head of Client Knowledge, who has also worked as a Software Trainer and Senior Sales Engineer at Hannon Hill. Bigger files, syntax highlighting, keyboard shortcuts, and code completion are a dream come correct for programmers using Cascade Server.

&#13

Other attributes to note are the new Generic Migration Tool, which will let customers to migrate generic HTML content into Cascade Server utilizing XPath, the potential to reorder metadata fields utilizing a drag-n-drop interface, and XML configuration for supporting bigger sets of field values. The new version also supplies support for Java 7.

&#13

Hannon Hills buyers have been notified of the release and can download and set up the newest version by visiting the Cascade Server Downloads Page. For much more data, please see the Cascade Server 7.4 Release Notes.

&#13

About the Firm

&#13

Situated in Atlanta, GA, Hannon Hill is the creator of Cascade Server, the most extensively utilized enterprise content material management technique for higher education. Created with colleges and universities in mind, Cascade Server gives larger education, government, technology, healthcare and non-profit organizations the freedom to manage their web presence with ease and cutting edge technologies. It is engineered for any network atmosphere, gives a content contributor-friendly interface, and provides deployment flexibility, robust multi-site management and a quickly implementation.

&#13

Since its founding in 2001, Hannon Hill options have been utilized and trusted by much more greater education institutions than any other CMS. Over 190 organizations in higher education use Cascade Server, like Emory University, The College of William &amp Mary, Northwestern University, University of Saskatchewan, and Texas A&ampM University, amongst numerous others. For far more information about Hannon Hill and its goods, please visit http://www.HannonHill.com or get in touch with the organization directly at 800-407-3540.

&#13
&#13
&#13
&#13
&#13

Connected Administrator Press Releases

Canada Passes Faster Removal of Foreign Criminals Act: Reports FWCanada

Posted on by


Montreal, Quebec (PRWEB) June 28, 2013

On June 20, 2013, Citizenship and Immigration Canada (CIC) announced that the More quickly Removal of Foreign Criminals Act, also identified as Bill C-43, became law in Canada. Initially proposed by the Minister of Citizenship, Immigration, and Multiculturalism Jason Kenney, the new law enables the Canadian government to bypass the Immigration Appeal Board (IAD) to deport foreign nationals and permanent residents with a crime conviction.

&#13

Measures taken to improve the efficiency and timeliness of appeals are only good if there are mechanisms to ensure that individuals with severe and valid claims have the chance to be heard before getting deported mentioned Marisa Feil, supervising attorney at FWCanada.

&#13

The Quicker Removal of Foreign Criminals Act is an amendment to the Immigration and Refugee Act. It increases the energy of the administration to remove convicted foreign nationals, prevent possible offenders from Canada, and take down barriers for benign visitors entering the country.Especially, it limits access to the IAD to those who get a punishment of six months in jail.

&#13

Prior to the new law, Canadian permanent residents who have been convicted of severe crimes could appeal to the IAD of the Immigration and Refugee Board. Due to the previous procedure, offenders of foreign nationalities could delay their deportation for a lot of years.

&#13

“Canadians are generous and welcoming people, but they have no tolerance for criminals and fraudsters abusing our generosity. We want an immigration program that is open to genuine visitors, whilst prevents the entry of foreign criminals and denies them the capacity to endlessly abuse our generosity,” mentioned Minister Kenney.

&#13

According to CIC, the amendment is supported by a lot of law enforcement and immigrant organizations, which includes the Canadian Association of Police Chiefs, the Canadian Police Association, Victims of Violence, and Immigrants for Canada.

&#13

The adjust prevents criminals from viewing Canada as a place exactly where they can escape from taking duty for their crimes. CIC emphasizes that the appeal procedure is reserved for individuals who deserve humanitarian considerations, not for criminals to delay their deportation by generating endless appeals.

&#13

Other than producing the deportation approach a lot more efficient, the newly established law offers authority to the Minister of Immigration to deny short-term entry to people who carry possible safety threats and grant entry to low-danger folks.

&#13

Though the original Bill C-43 has turn out to be law, it has generated a lot controversy from its initial stages. A September 24, 2012 report published by CBC News reveals that critics of Bill C-43 are concerned that this gives too a lot energy to the administration, which might use it as a political tool. Final year, the National Immigration Law Section of the Canadian Bar Association (CBA) also published a recommendation to Bill C-43, urging policymakers to remove the bill or substantially amend it since it violated the correct to appeal for Canadian permanent residents.

&#13

In spite of of the concern and criticism, the More rapidly Removal of Foreign Criminals Act is now in effect.

&#13

About FWCanada:&#13

FWCanada is a Canadian Immigration Law Firm which supplies expertise in immigration solutions such as Short-term Resident Permits, Criminal Rehabilitation, Study Permits and Perform Permits. Marisa Feil and her team guarantee that every single case is closely evaluated to establish the most relevant plan. For far more information, contact FWCanada at 1-855-316-3555.

&#13
&#13
&#13
&#13
&#13

Bel Marra Wellness Reports on New Study Revealing the Newest FDA-Authorized Antibiotic Human Stool

Posted on by


Toronto, ON (PRWEB) June 29, 2013

Bel Marra Wellness, who provides higher-high quality, specially formulated vitamins and nutritional supplements, reports on a new study revealing human stool transplants as an FDA-approved process.

&#13

As Bel Marra Health reports in its report, (http://www.belmarrahealth.com/colon-and-digestive/the-newest-fda-approved-antibiotic-human-stool), a fecal transplant is a procedure that involves infusing stool from a healthier human donor into the intestines of an ill patient in order to re-establish healthier micro-organisms in the individuals gut. Healthy microbes operate related to antibiotic drugs, simply because they aid to fight off harmful micro-organisms in the physique. Fecal transplants have been employed by medical doctors for years as a type of antibiotic therapy to treat a range of ailments, and the procedure is steadily developing in popularity.

&#13

Throughout a public workshop in May, the Meals and Drug Administration (FDA) announced that it planned to take authority over fecal transplants, which means that fecal transplants would be stringently regulated in the same way that drugs are. As such, researchers would be essential to file for an Investigative New Drug application prior to continuing to carry out fecal transplants. The truth that the FDA planned to regulate and standardize fecal transplants as opposed to banning them was a nod to its effectiveness as an (unconventional) antibiotic procedure.

&#13

As fecal transplants were previously practiced in an unregulated environment, therapies have constantly widely varied from practitioner to practitioner. Some medical doctors use enemas to administrate the stool into the reduced colon, while other people carry out the transplant through a colonoscopy, which is much more invasive but guarantees that the stool is transplanted additional up into the intestines. Other practitioners administrate the stool microbes through a tube inserted down the patient’s nose and throat, or wrap the stool microbes in triple layered gelatin capsules and have their sufferers take it orally. Presently, the fecal matter used for fecal transplants comes from human feces, and ideally from a blood relative however, in the future, synthetic stool could be created as a safer and more sterile therapy alternative.

&#13

A evaluation of data from 300 patients identified that fecal transplants cure about 92% of sufferers experiencing recurring C. difficile infections (an increasingly frequent infection that can be fatal and usually resistant to antibiotic drugs). Most researchers dont argue the effectiveness of fecal transplants for the treatment of C. difficile infections, and some little case studies even help the use of fecal transplants for therapy of Crohns disease, inflammatory bowel illness and numerous sclerosis. However, some researchers are recommending fecal transplants for the treatment of Parkinsons illness and autism spectrum disorder, despite a existing lack of proof to support this method.

&#13

Even though regulation of fecal transplants appears like a logical step to make certain their availability and safety to the public, the FDAs strategy to take the reins of this transplant procedure was met with frustration from many medical doctors and researchers. Practitioners of stool transplants complained that such centralized regulation would imply that a number of sick patients would have to be place on hold or turned away, with all the new paper function (Investigative New Drug applications, or INDs, would have to be filled out and approved prior to each process) and approval processes that would turn out to be involved. Groups such as the American Gastroenterological Association lobbied against the FDA regulation, because the time delay for obtaining the IND application authorized would unnecessarily stall a life-saving remedy for patients. As a result of this lobbying, just weeks right after the FDAs plan to regulate fecal transplants was announced, the FDA was forced to re-negotiate its regulatory pursuit, allowing doctors to continue delivering fecal transplants without having any sort of IND approval or regulation from the FDA after all.

&#13

At this point, it is uncertain if and when the FDA will choose up its petition to regulate stool transplant once more. Nevertheless, in the meantime, medical doctors are needed to document that they have informed their sufferers about the rewards and dangers of the fecal transplant process, and are needed to make it clear to individuals that the procedure is investigational and not however clinically verified.

&#13

(Supply: Sachin Kunde, et al. Security, Tolerability, and Clinical Response following Fecal Transplantation in Kids and Young Adults with Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition, 2013 : 1 DOI: 10.1097/MPG.0b013e318292fa0d)

&#13

Bel Marra Health is the maker of “Healthier Colon,” a high-good quality nutritional supplement that includes 14 organic components to relieve gas, constipation, and bloating. All components are backed with scientific proof. Each and every item is tested for security, high quality, and purity at every stage of the manufacturing procedure. Furthermore, Bel Marra Overall health products are produced only in Wellness Canada authorized facilities, going the further mile to guarantee that our overall health-conscious buyers are receiving best high quality products. For far more details on Bel Marra Health, check out belmarrahealth.com or get in touch with 1-866-531-0466.

&#13
&#13
&#13
&#13
&#13

Biomet Hip Lawsuits Move Forward, As Bernstein Liebhard LLP Reports on Latest Case Management Conference in Federal Biomet Hip Replacement Litigation

Posted on by


New York, New York (PRWEB) July 01, 2013

Hundreds of Biomet hip lawsuits involving the Biomet M2a Magnum Hip Replacement Program continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Northern District of Indiana. According to a Memorandum issued by the Court on June 24th, the Biomet hip replacement litigations most recent case management conference was held on June 17, 2013, at which time a quantity of issues had been addressed, including pending motions to strike affirmative defenses, jurisdictional issues connected to the current dismissal of improperly named defendants, and the use of a kind complaint. At the conclusion of the conference, the parties presented a tutorial on the scientific and technical issues involved in the Biomet hip replacement lawsuits. (In re: Biomet M2a Magnum Hip Implant Items Liability Litigation MDL No. 2391)

&#13

This most current conference addressed a number of crucial concerns. We are pleased to see the Biomet hip replacement litigation moving ahead, and look forward to extra progress in the future, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and healthcare devices. The Firm is representing customers in Biomet hip lawsuits in the federal multidistrict litigation, and continues to supply free of charge and confidential case evaluations to people who may possibly have been injured by Biomet M2a Magnum implants.

&#13

Biomet Hip Replacement Lawsuits&#13

Court documents indicate that far more than 300 Biomet hip lawsuits are now pending in the federal multidistrict litigation. All of the claims allege the Biomet M2a Magnum implants metal-on-metal design can shed dangerous amounts of toxic metal debris as a outcome of wear, top to metallosis and other adverse tissue reactions, as effectively as premature device failure. According to the June 17th Memorandum, the Biomet hip replacement litigations next case management conference has been scheduled for September 23, 2013, whilst a telephonic status conference is set for July 29, 2013.

&#13

The U.S. Meals &amp Drug Administration (FDA) has been reviewing the security of metal-on-metal hip implants like the Biomet M2a Magnum considering that February 2011. In January, the FDA warned that the metal debris shed from these devices can trigger damage to bone and/or tissue surrounding the implant and joint, top to discomfort, implant loosening, device failure, and the want for revision surgery to replace the device. At that time, the agency advised recipients of metal-on-metal hip replacements to undergo metal ion testing if they are experiencing symptoms of hip implant failure. The FDA also stated it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which allowed such devices to come to market place with out first undergoing human clinical trials.*

&#13

Alleged victims of metal-on-metal hip implant complications associated to the Biomet M2a Magnum hip could be entitled to compensation for their medical expenditures, lost wages and discomfort and suffering. To understand far more about the Biomet hip replacement litigation, please check out Bernstein Liebhard LLPs website. For further data about filing a Biomet hip lawsuit, please contact 1 our attorneys today at 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated individual and class action lawsuits nationwide given that 1993, such as these who have been harmed by dangerous drugs, defective health-related devices and customer merchandise. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Advertising.

GranuFlo Lawsuit Update: New Filings Highlight Alleged Hyperlink of GranuFlo to Cardiac Arrest, Reports Audet and Partners, LLP

Posted on by


San Francisco, CA (PRWEB) July 01, 2013

A new federal lawsuit filed in the United States District Court for the Southern District of Iowa (Case No. three:2013cv00073) alleges that the dialysis drug GranuFlo triggered the plaintiff to endure a heart attack shortly following dialysis therapy, causing a fatal collision.* This case has been added to federal multidistrict litigation No.2428 now pending before Judge Douglas P. Woodlock in Massachusetts, which lists 161 pending instances as component of this litigation.**

&#13

Numerous internal memoranda circulated inside Fresenius, the maker of GranuFlo, suggest that Fresenius might have identified of the heart attack threat associated with its merchandise use, even prior to an FDA recall.*** This enhanced danger is linked to elevated bicarbonate levels, a contributing factor in cardiac arrest.***

&#13

Since of the hazardous nature of GranuFlo, the FDA has issued a Class I recall of GranuFlo.**** In issuing the recall, the FDA warned buyers that the elevated sodium bicarbonate levels, could contribute to metabolic alkalosis, which is a substantial threat issue associated with low blood stress, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest.**** The FDA concluded by stating that the serious adverse wellness consequences related with GranuFlo could even consist of death.****

&#13

Attorney William Audet, whose law firm Audet and Partners, LLP represents several plaintiffs in active lawsuits against Fresenius, is not surprised by the new lawsuit filings. “The complaints being added to the multidistrict litigation echo troubles articulated by men and women with whom we continue to speak on a weekly basis. These problems frequently involve heart attacks or cardiac arrest occurring inside hours following dialysis treatment options involving the administration of GranuFlo. The evidence emerging by way of discovery suggests that Fresenius may possibly have failed to act in a responsible style upon becoming conscious of this potential heart attack hyperlink a number of years ago.”

&#13

If you or somebody you know has suffered an injury that might be connected to GranuFlo, please get in touch with Audet &amp Partners, LLP by calling us toll cost-free at 800.965.1461. For extra data, you can visit our informational internet site at http://www.granuflodialysisrisk.com. &#13

&#13
U.S. District Court for the Southern District of Iowa, Case No. 3:2013cv00073

** United States Judicial Panel on Multidistrict Litigation, May 14, 2013 http://www.jpml.uscourts.gov/websites/jpml/files/Pending%20MDL%20Dockets_By%20District_Could-14-2013.pdf

&#13

*** New York Times, June 15, 2012 http://www.nytimes.com/2012/06/15/wellness/fda-investigates-fresenius-for-failure-to-warn-of-risk.html

&#13

**** FDA, May 25, 2012 http://www.fda.gov/Security/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305630.htm

&#13
&#13
&#13
&#13
&#13

Far more Administrator Press Releases

Transvaginal Mesh Lawsuit News: Federal Judge Overseeing American Healthcare Systems Surgical Mesh Lawsuits Selects Bellwether Instances, Bernstein Liebhard LLP Reports

Posted on by


New York, New York (PRWEB) July 02, 2013

Transvaginal mesh lawsuit claims involving items manufactured by American Medical Systems, Inc. continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Pretrial Order issued by the Court on July 1, 2013, four surgical mesh lawsuits have been chosen for the litigations bellwether trials. The proceedings initial trial is scheduled to start on December 3, 2013, even though a second is slated to start off on Might six, 2014. U.S. District Judge Joseph R. Goodwin will soon establish which of the 4 bellwether instances will go to trial on those dates, according to the Order. (In Re: American Health-related Systems, Inc., Pelvic Repair Systems Items Liability Litigation – MDL No. 2325)

&#13

We are incredibly pleased to see these claims moving forward. The bellwether trials will give important clues into how other juries may possibly weigh claims in similar surgical mesh lawsuits involving American Medical Systems, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and health-related devices. The Firms vaginal mesh lawyers are currently representing hundreds of girls who allegedly suffered mesh erosion, discomfort, scarring, infection and other serious injuries, allegedly due to transvaginal mesh merchandise marketed by American Health-related Systems and other manufacturers. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs Steering Committee in the American Healthcare Systems litigation.

&#13

American Health-related Systems Transvaginal Mesh Lawsuits

&#13

Court documents indicate that a lot more than 7,700 surgical mesh lawsuits have been filed against American Healthcare Systems in the Southern District of West Virginia. All of the lawsuits pending in the litigation allege that American Healthcare Systems failed to provide adequate warnings with regards to the dangers linked with surgical mesh utilized to treat pelvic organ prolapse and stress urinary incontinence. It is additional alleged that plaintiffs suffered a range of serious complications due to the defective nature of these items, including chronic infections, organ harm, and mesh erosion and shrinkage.

&#13

The litigation surrounding transvaginal mesh devices utilized to treat pelvic organ prolapse and stress urinary incontinence has been expanding given that October 2008, when the U.S. Food &amp Drug Administration (FDA) warned the public that it had received a lot more than 1,000 reports of serious complications linked with vaginal mesh products over a 3 year period.* Less than 3 years later, in July 2011, the FDA warned that complaints related with transvaginal prolapse repair had grown 5-fold because the 2008 alert, and stated that it no longer regarded as these varieties of injuries to be uncommon.**

&#13

American Healthcare Systems is just 1 of many producers involved in litigations for surgical mesh lawsuits established in the Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs Steering Committees for proceedings involving Boston Scientific Corp., (MDL No. 2326) C.R. Bard, Inc., (MDL No. 2187), and In re: Ethicon, Inc. (MDL No. 2327). Court documents show that the very first of the litigations bellwether trials, involving a C.R. Bard product, is scheduled to start on July 8, 2013.

&#13

Mr. Grand has also been named Co-Liaison Counsel in two consolidated litigations established for C.R. Bard and Ethicon transvaginal mesh lawsuits that are at present underway in New Jerseys Atlantic County Superior Court. He was also a member of the trial group on the very first Ethicon trial in that proceeding, which ended in March with an $ 11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-ten In re: Pelvic Mesh Litigation/Bard, No. L-6339-ten)

&#13

Ladies who have allegedly suffered severe complications related with transvaginal mesh may possibly be entitled to compensation for their healthcare bills, discomfort and suffering, and other injuries. A wealth of data with regards to transvaginal mesh lawsuits is obtainable at Bernstein Liebhard’s web site. To arrange for a free of charge legal consultation with an experienced mesh lawyer, please get in touch with the Firm these days by calling 800-511-5092.

&#13

*fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079028.htm&#13

**fda.gov/MedicalDevices/Security/AlertsandNotices/PublicHealthNotifications/ucm061976.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated person and class action lawsuits nationwide given that 1993, such as these who have been harmed by dangerous drugs, defective healthcare devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.

TAG Oil Reports 2013 Fiscal Year Finish Economic Results and 2014 Drilling System

Posted on by


Vancouver, B.C. (PRWEB) July 02, 2013

TAG Oil Ltd. (TSX: TAO) and (OTCQX: TAOIF), reports the Company has filed its consolidated, audited financial statements, management discussion and analysis and annual information form with the Canadian Securities Administrators for the Company’s March 31, 2013 fiscal year-end. Copies of these documents can be obtained electronically at http://www.sedar.com, or for additional information please visit TAG Oil’s website at http://www.tagoil.com/.

Conference Call

TAG Oil also hosted a discussion of its 2014 forward program, as well as fourth quarter 2013 results on Friday June 28, 2013. Access a transcript or audio file of that call here:

http://www.tagoil.com/TAG-Oil-Earnings-Call-F4Q13.asp.

Interested parties may also access a replay of the call until 11:59 p.m. Friday, July 5, 2013 using the information below:

Toll-Free Dial-in #

DePuy Pinnacle Lawsuits Continue to Mount, as Federal Claims Exceed 4,400, Bernstein Liebhard LLP Reports

Posted on by


New York, NY (PRWEB) July 03, 2013

DePuy Pinnacle lawsuit claims involving an all-metal version of the DePuy Pinnacle Hip Replacement Program continue to mount in the federal multidistrict litigation underway in U.S. District Court, Northern District of Texas, Bernstein Liebhard LLP reports. According to a Master Case List issued by the Court on July 1, 2013, 4,445 DePuy Pinnacle hip replacement lawsuits were pending in the proceeding as of June 30th. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244 N.D. Texas)

&#13

Our Firm continues to receive inquiries from individuals who have suffered metallosis, premature device failure and other serious complications allegedly related with the metal-on-metal DePuy Pinnacle hip replacement. We anticipate that filings in this litigation will continue to increase in the coming months, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and health-related devices. Jeffrey S. Grand, a companion with Bernstein Liebhard LLP, serves on the Plaintiffs Steering Committee for the federal litigation, while the Firms DePuy Pinnacle lawyers continue to offer you cost-free legal evaluations to alleged victims of severe complications connected with the all-metal DePuy Pinnacle Hip Replacement Method.

&#13

DePuy Pinnacle Hip Replacement Lawsuits&#13

All of the DePuy Pinnacle hip replacement lawsuits pending in the Northern District of Texas involve a version of the Pinnacle hip method that utilized the Ultamet liner. According to court documents, plaintiffs allege that they have suffered premature implant failure, metallosis and other serious complications due to the propensity of the device to shed dangerous amounts of metal ions into the tissue surrounding the implant, as effectively as the blood stream. The lawsuits further allege that the all-metal Pinnacle shares some of the same style flaws that prompted DePuy Orthopaedics to recall its ASR line of metal hip implants in 2010, and question no matter whether this version of Pinnacle program must have been recalled as properly.

&#13

Even though it does not seem that a DePuy Pinnacle recall is imminent, DePuy Orthopaedics did announce in May possibly that it would be ending sales of all-metal hips, which includes the metal-on-metal Pinnacle. While the firm did not cite the increasing number of DePuy Pinnacle hip replacement lawsuits as a contributing issue to this selection, it did note that demand for metal-on-metal hips has slipped in recent years. According to a May 17th report from The New York Occasions, DePuy also cited a proposed regulation from the U.S. Food &amp Drug Administration (FDA) that would demand the producers of metal-on-metal hips at the moment on the industry to conduct post-marketplace safety research in order to preserve promoting the goods.*

&#13

Victims of significant complications allegedly associated with the metal-on-metal DePuy Pinnacle hip implant may possibly be entitled to compensation for their healthcare care, discomfort and suffering, and other damages. Added details about filing a DePuy Pinnacle hip replacement lawsuit is offered at Bernstein Liebhards site. For a free, no obligation legal consultation with a DePuy Pinnacle lawyer, please call 800-511-5092 today.

&#13

*nytimes.com/2013/05/17/company/jj-is-phasing-out-metal-replacement-hips.html?ref=health&amp_r=

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide since 1993, which includes these who have been harmed by dangerous drugs, defective health-related devices and customer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Advertising.

Mirena Lawsuits Move Ahead, as Case Management Conference is Convened in New Jersey Litigation, Bernstein Liebhard LLP Reports

Posted on by


New York, New York (PRWEB) July 04, 2013

Mirena lawsuit claims filed on behalf of ladies who have allegedly suffered significant complications, such as spontaneous device migration and uterine perforations, due to their use of the IUD, are moving forward in each state and federal courts, Bernstein Liebhard LLP reports. Court documents indicate that a Case Management Conference was held on July 1st in the consolidated litigation established for Mirena IUD lawsuits in New Jerseys Bergen County Superior Court. According to an Order issued by the Court on July 2nd, attorneys for the parties have been directed to meet and confer within 30 days to reach agreement on a quantity of issues, including the status, scope, parameters and timing of discovery. The Court also scheduled the litigations next Case Management Conference for August 13, 2013. (In Re: Mirena Litigation Case No. 297)

&#13

Our Firm is actively representing women in Mirena lawsuits, and we continue to hear from alleged victims of critical Mirena complications, including spontaneous device migration and uterine perforations. We are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to provide free of charge legal evaluations to alleged victims of Mirena side effects.

&#13

Mirena IUD Lawsuits&#13

The Mirena IUD was approved by the U.S. Food &amp Drug Administration (FDA) as a birth control strategy in 2000, and later as a remedy for heavy menstrual bleeding in females who wish to use an IUD as their main form of birth handle. According to court documents, Mirena lawsuits allege that Bayer Healthcare Pharmaceuticals downplayed its severe risks and failed to supply sufficient warnings concerning the prospective for spontaneous migration of the Mirena IUD. In addition to the consolidated litigation now underway in New Jersey Superior Court, a multidistrict litigation was not too long ago established in U.S. District Court, Southern District of New York for all federally-filed Mirena IUD lawsuits. A Status Conference in the federal multidistrict litigation was held on July 2nd. (In re: Mirena IUD Items Liability Litigation, MDL No. 2434)

&#13

According to a June 17th report from NewsChannel5 in Cleveland, the FDA has received more than 70,000 adverse occasion reports involving Mirena given that the device was launched in 2000. Information from the FDA also indicated that given that 2008, the agency had received a lot more than 4,700 complaints of device dislocation involving Mirena, and 1,300 reports of uterine perforations. Despite these mounting adverse event reports, there has been no indication that Bayer may be arranging to announce a Mirena IUD recall any time in the future.*

&#13

Whilst a Mirena recall does not appear imminent, the FDA has taken problem in the past with some of the claims Bayer has utilised in marketing campaigns for the IUD. In 2009, the agency issued a warning letter to Bayer after obtaining that its Mirena promotions overstated the efficacy of the device and minimized its dangers. Amongst other items, the letter cited Bayer for producing statements that indicated that Mirena would assist a lady look and really feel wonderful, and enhance her sex life.**

&#13

Ladies who have allegedly suffered significant Mirena complications following spontaneous migration of the IUD may be entitled to compensation for their health-related bills, lost wages, discomfort and suffering and other damages. To find out a lot more about Mirena lawsuits, please go to Bernstein Liebhard LLPs site. To arrange for a cost-free evaluation of your potential Mirena IUD lawsuit, please contact 800-511-5092.

&#13

*newsnet5.com/dpp/news/local_news/investigations/thousands-of-females-complain-about-harmful-complications-from-mirena-iud-birth-handle&#13

*http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM197229.pdf

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide because 1993, such as these who have been harmed by harmful drugs, defective medical devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.